Variant report

Variant	nsv887812
Chromosome Location	chr7:18548719-18622368
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr7:18548655-18548770	K562	blood:	n/a	n/a
2	ATF2	chr7:18547978-18548946	GM12878	blood:	n/a	n/a
3	ATF2	chr7:18548048-18548812	GM12878	blood:	n/a	n/a
4	ATF2	chr7:18578011-18578535	GM12878	blood:	n/a	n/a
5	BACH1	chr7:18615915-18615917	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr7:18586144-18586612	H1-hESC	embryonic stem cell:	n/a	n/a
7	BATF	chr7:18578064-18578388	GM12878	blood:	n/a	n/a
8	BATF	chr7:18572511-18572786	GM12878	blood:	n/a	n/a
9	BCL11A	chr7:18598156-18598448	GM12878	blood:	n/a	n/a
10	BCL3	chr7:18606509-18606783	GM12878	blood:	n/a	n/a
11	BCLAF1	chr7:18548067-18548894	GM12878	blood:	n/a	chr7:18548274-18548283 chr7:18548273-18548282 chr7:18548815-18548824 chr7:18548868-18548877
12	BHLHE40	chr7:18577935-18578578	GM12878	blood:	n/a	n/a
13	BHLHE40	chr7:18570580-18570733	GM12878	blood:	n/a	n/a
14	CBX3	chr7:18548009-18549139	HCT-116	colon:	n/a	n/a
15	CEBPB	chr7:18548132-18549791	IMR90	lung:	n/a	chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549630 chr7:18549617-18549628 chr7:18549617-18549630
16	CEBPB	chr7:18554636-18555021	IMR90	lung:	n/a	chr7:18554858-18554871
17	CEBPB	chr7:18547929-18549114	HCT-116	colon:	n/a	n/a
18	CEBPB	chr7:18606453-18606792	IMR90	lung:	n/a	chr7:18606463-18606474 chr7:18606464-18606476
19	CEBPB	chr7:18603140-18603209	HepG2	liver:	n/a	chr7:18603175-18603186 chr7:18603177-18603186
20	CEBPB	chr7:18549651-18549663	H1-hESC	embryonic stem cell:	n/a	n/a
21	CEBPB	chr7:18613011-18613092	HepG2	liver:	n/a	n/a
22	CEBPB	chr7:18554705-18554925	Hela-S3	cervix:	n/a	chr7:18554858-18554871
23	CEBPB	chr7:18606500-18606695	HepG2	liver:	n/a	n/a
24	CEBPB	chr7:18549496-18549703	K562	blood:	n/a	chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549630 chr7:18549617-18549628 chr7:18549617-18549630
25	CEBPB	chr7:18554766-18554911	A549	lung:	n/a	chr7:18554858-18554871
26	CEBPB	chr7:18549544-18549790	HepG2	liver:	n/a	chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549628 chr7:18549619-18549630 chr7:18549617-18549628 chr7:18549617-18549630
27	CEBPB	chr7:18560281-18560634	IMR90	lung:	n/a	n/a
28	CEBPB	chr7:18603060-18603320	IMR90	lung:	n/a	chr7:18603304-18603316 chr7:18603175-18603186 chr7:18603177-18603186
29	CEBPB	chr7:18572901-18573040	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr7:18606442-18606806	H1-hESC	embryonic stem cell:	n/a	chr7:18606463-18606474 chr7:18606464-18606476
31	CEBPB	chr7:18554695-18554960	H1-hESC	embryonic stem cell:	n/a	chr7:18554858-18554871
32	CEBPB	chr7:18614344-18614544	HepG2	liver:	n/a	n/a
33	CEBPB	chr7:18595087-18595160	HepG2	liver:	n/a	n/a
34	CHD2	chr7:18548866-18549134	H1-hESC	embryonic stem cell:	n/a	n/a
35	CHD2	chr7:18561697-18561813	GM12878	blood:	n/a	n/a
36	CREB1	chr7:18592680-18592850	A549	lung:	n/a	n/a
37	CTCF	chr7:18610602-18610811	LNCaP	prostate:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
38	CTCF	chr7:18610700-18610850	WI-38	lung:	n/a	n/a
39	CTCF	chr7:18557100-18557250	NHDF-neo	bronchial:	n/a	n/a
40	CTCF	chr7:18610603-18610759	SK-N-SH_RA	brain:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
41	CTCF	chr7:18610720-18610870	NHLF	lung:	n/a	n/a
42	CTCF	chr7:18610580-18610730	GM06990	blood:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
43	CTCF	chr7:18610620-18610770	HUVEC	blood vessel:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
44	CTCF	chr7:18610420-18610965	HCT-116	colon:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
45	CTCF	chr7:18610584-18610821	Hela-S3	cervix:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
46	CTCF	chr7:18610660-18610810	HUVEC	blood vessel:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
47	CTCF	chr7:18610599-18610800	GM10266	blood:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
48	CTCF	chr7:18610680-18610830	HCPEpiC	choroid plexus:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
49	CTCF	chr7:18610631-18610770	K562	blood:	n/a	chr7:18610687-18610708 chr7:18610692-18610710
50	CTCF	chr7:18610640-18610790	AG09319	gingival:	n/a	chr7:18610687-18610708 chr7:18610692-18610710

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:18591072-18591122	T-47D	breast:	n/a
2	chr7:18591072-18591122	HIPEpiC	eye:	n/a
3	chr7:18591072-18591122	HAEpiC	amniotic membrane:	n/a
4	chr7:18591072-18591122	HUVEC	blood vessel:	n/a
5	chr7:18591072-18591122	ECC-1	luminal epithelium:	n/a
6	chr7:18575633-18575683	HCPEpiC	choroid plexus:	n/a
7	chr7:18591072-18591122	Caco-2	colon:	n/a
8	chr7:18575633-18575683	PFSK-1	brain:	n/a
9	chr7:18575633-18575683	HIPEpiC	eye:	n/a
10	chr7:18575633-18575683	ECC-1	luminal epithelium:	n/a
11	chr7:18591072-18591122	H1-hESC	embryonic stem cell:	embryo
12	chr7:18591072-18591122	SK-N-MC	brain:	n/a
13	chr7:18591072-18591122	Hela-S3	cervix:	n/a
14	chr7:18591072-18591122	GM06990	blood:	n/a
15	chr7:18575633-18575683	HRPEpiC	eye:	n/a
16	chr7:18575633-18575683	GM06990	blood:	n/a
17	chr7:18575633-18575683	U87	brain:	n/a
18	chr7:18591072-18591122	HCM	heart:	n/a
19	chr7:18575633-18575683	RPTEC	kidney:	n/a
20	chr7:18591072-18591122	MCF10A-Er-Src	breast:	n/a
21	chr7:18575633-18575683	HCF	heart:	n/a
22	chr7:18575633-18575683	NH-A	brain:	n/a
23	chr7:18591072-18591122	NH-A	brain:	n/a
24	chr7:18575633-18575683	BJ	skin:	n/a
25	chr7:18575633-18575683	HAEpiC	amniotic membrane:	n/a
26	chr7:18575633-18575683	HMEC	breast:	n/a
27	chr7:18591072-18591122	IMR90	lung:	fetal
28	chr7:18575633-18575683	Caco-2	colon:	n/a
29	chr7:18591072-18591122	PANC-1	pancreas:	n/a
30	chr7:18575633-18575683	Hepatocyte	liver:	n/a
31	chr7:18591072-18591122	HEEpiC	esophagus:	n/a
32	chr7:18591072-18591122	AG04449	skin:	fetal
33	chr7:18575633-18575683	AG09309	skin:	n/a
34	chr7:18575633-18575683	GM19239	blood:	n/a
35	chr7:18591072-18591122	HepG2	liver:	n/a
36	chr7:18591072-18591122	K562	blood:	n/a
37	chr7:18591072-18591122	SK-N-SH	brain:	n/a
38	chr7:18575633-18575683	NHDF-neo	bronchial:	n/a
39	chr7:18575633-18575683	SK-N-SH	brain:	n/a
40	chr7:18575633-18575683	K562	blood:	n/a
41	chr7:18575633-18575683	SAEC	small airway:	n/a
42	chr7:18575633-18575683	A549	lung:	n/a
43	chr7:18575633-18575683	HEK293	kidney:	embryo
44	chr7:18575633-18575683	MCF-7	breast:	n/a
45	chr7:18591072-18591122	NT2-D1	testis:	n/a
46	chr7:18591072-18591122	SK-N-SH_RA	brain:	n/a
47	chr7:18575633-18575683	AG09319	gingival:	n/a
48	chr7:18591072-18591122	SAEC	small airway:	n/a
49	chr7:18591072-18591122	HEK293	kidney:	embryo
50	chr7:18575633-18575683	PANC-1	pancreas:	n/a

No.	Distal block	Cell Line	Cell type
1	chr7:18614577..18617319-chr7:18617831..18619688,2	MCF-7	breast:
2	chr21:38311417..38312168-chr7:18570337..18570856,2	MCF-7	breast:
3	chr7:18614577..18617319-chr7:18617831..18619688,2	MCF-7	breast:
4	chr7:18391676..18392589-chr7:18610144..18611124,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AHR-8	chr7:18557281-18557694	NONHSAT119367

Variant related genes	Relation type
HDAC9	TF binding region
HDAC9	CpG island

Extended variants
information (count: 2825 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:2825 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2520460	chr7:18548719-18548720	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs543619930	chr7:18548771-18548772	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs541658715	chr7:18548840-18548841	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs532430564	chr7:18548902-18548903	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs116166394	chr7:18548916-18548917	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs548191178	chr7:18548932-18548933	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs563335289	chr7:18548934-18548935	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs530517729	chr7:18548935-18548936	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs552203096	chr7:18549013-18549014	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs570463569	chr7:18549027-18549028	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs3807924	chr7:18549059-18549060	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs115105201	chr7:18549114-18549115	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs546412793	chr7:18549115-18549116	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs111791870	chr7:18549131-18549132	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs547197187	chr7:18549143-18549144	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs181433788	chr7:18549145-18549146	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs554659341	chr7:18549151-18549152	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs186540462	chr7:18549193-18549194	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs565623729	chr7:18549197-18549198	Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs3807923	chr7:18549205-18549206	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs113248159	chr7:18549246-18549247	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs114300525	chr7:18549254-18549255	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs35536634	chr7:18549264-18549265	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs117340057	chr7:18549281-18549282	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs188502799	chr7:18549301-18549302	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs541614677	chr7:18549319-18549320	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs560022145	chr7:18549321-18549322	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs181636360	chr7:18549330-18549331	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs528504496	chr7:18549365-18549366	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs147767510	chr7:18549369-18549370	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs74955002	chr7:18549377-18549378	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs185965890	chr7:18549385-18549386	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs542591826	chr7:18549386-18549387	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs563830318	chr7:18549387-18549388	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs567168954	chr7:18549390-18549391	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs144216864	chr7:18549448-18549449	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs146630944	chr7:18549466-18549467	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs375838155	chr7:18549476-18549477	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs17139278	chr7:18549510-18549511	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs528201468	chr7:18549579-18549580	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs546375995	chr7:18549582-18549583	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs35848123	chr7:18549654-18549655	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs567957811	chr7:18549748-18549749	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs114969937	chr7:18549793-18549794	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs536310333	chr7:18549794-18549795	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs569070801	chr7:18549808-18549809	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs537421846	chr7:18549813-18549814	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs115854359	chr7:18549815-18549816	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs577399436	chr7:18549868-18549869	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs191127861	chr7:18549907-18549908	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Autism	22495311	CNVD
Prostate cancer	16573809	CNVD
Acute myeloid leukemia	21251322	CNVD
Kartagener syndrome	16639409	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Prostate cancer	19242612	CNVD
Autism	18414403	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21858162	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Cancer	21637783	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16397240	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Glioblastoma multiforme	18628472	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Heart disease	21282601	CNVD
Rubinstein-Taybi syndrome	22470819	CNVD
Alzheimer''s disease	22166940	CNVD
Abnormal phenotypes	18644119	CNVD
Non-syndromic sensorineural hearing loss	22570644	CNVD
Bladder cancer	21909424	CNVD
Cancer	21183584	CNVD
Autism	20808228	CNVD
Sezary syndrome	18413736	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:1214 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:18538200-18548800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr7:18541800-18551600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr7:18542000-18553200	Weak transcription	Sigmoid Colon	Sigmoid Colon
4	chr7:18542200-18548800	Weak transcription	Brain Anterior Caudate	brain
5	chr7:18543000-18549600	Enhancers	Primary B cells from peripheral blood	blood
6	chr7:18543000-18554400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr7:18544600-18548800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr7:18544800-18548800	Weak transcription	Left Ventricle	heart
9	chr7:18545600-18554200	Weak transcription	Fetal Brain Female	brain
10	chr7:18545800-18548800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr7:18546000-18548800	Weak transcription	Adipose Nuclei	Adipose
12	chr7:18546000-18551000	Weak transcription	Brain Hippocampus Middle	brain
13	chr7:18546200-18551800	Enhancers	Primary B cells from cord blood	blood
14	chr7:18547600-18548800	Enhancers	NHLF	lung
15	chr7:18547600-18549000	Enhancers	Pancreatic Islets	Pancreatic Islet
16	chr7:18547800-18548800	Active TSS	Rectal Mucosa Donor 29	rectum
17	chr7:18547800-18549400	Enhancers	iPS-15b Cell Line	embryonic stem cell
18	chr7:18547800-18549400	Enhancers	Hela-S3	cervix
19	chr7:18547800-18549600	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr7:18548000-18548800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr7:18548000-18548800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr7:18548000-18549000	Enhancers	HUES6 Cell Line	embryonic stem cell
23	chr7:18548000-18549000	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr7:18548000-18549400	Enhancers	iPS-20b Cell Line	embryonic stem cell
25	chr7:18548000-18549600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr7:18548000-18550200	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr7:18548000-18551000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr7:18548200-18549000	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr7:18548200-18549000	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr7:18548200-18549000	Enhancers	Primary hematopoietic stem cells short term culture	blood
31	chr7:18548200-18549000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr7:18548200-18549200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr7:18548200-18549400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr7:18548200-18549400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr7:18548200-18549400	Enhancers	Fetal Muscle Leg	muscle
36	chr7:18548200-18549600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr7:18548200-18549800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
38	chr7:18548200-18549800	Flanking Active TSS	Osteobl	bone
39	chr7:18548200-18550800	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr7:18548400-18548800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
41	chr7:18548400-18548800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
42	chr7:18548400-18548800	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
43	chr7:18548400-18548800	Flanking Active TSS	HSMMtube	muscle
44	chr7:18548400-18549000	Active TSS	Primary T regulatory cells fromperipheralblood	blood
45	chr7:18548400-18549000	Enhancers	Cortex derived primary cultured neurospheres	brain
46	chr7:18548400-18549000	Enhancers	Brain Angular Gyrus	brain
47	chr7:18548400-18549000	Enhancers	Brain Cingulate Gyrus	brain
48	chr7:18548400-18549000	Enhancers	Brain Substantia Nigra	brain
49	chr7:18548400-18549200	Enhancers	H1 Cell Line	embryonic stem cell
50	chr7:18548400-18549200	Flanking Active TSS	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links